Through joint efforts of Tulane, the National Institutes of Health and the U.S. Army, a new vaccine has been developed that provides protection for the first time against equine encephalitic viruses in nonhuman primates. The encephalitic alphaviruses, spread by mosquitoes, are possible bioterrorism agents.